Reference : Actualites therapeutiques 2002 (1).
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/10590
Actualites therapeutiques 2002 (1).
French
[en] Therapeutic advances in 2002 (1)
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
2002
Revue Médicale de Liège
57
11
719-31
Yes (verified by ORBi)
National
0370-629X
Belgium
[en] Belgium ; Drug Therapy/trends ; Evidence-Based Medicine ; Humans ; Internal Medicine/trends ; Randomized Controlled Trials as Topic
[en] The most important drugs registered and/or launched in Belgium during the last year in the various disciplines of internal medicine will be briefly described. The main characteristics of each molecule and its modalities of appropriate use in clinical practice will be emphasized. For all these molecules, both the efficacy and tolerance have been proven in randomised clinical trials according to the rules of Evidence-Based Medicine.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/10590
http://www.rmlg.ulg.ac.be

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
200211_08.pdfNo commentaryPublisher postprint502.48 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.